{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T21:07:54Z","timestamp":1711487274625},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,7]]},"DOI":"10.7759\/cureus.28899","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T18:18:31Z","timestamp":1662574711000},"source":"Crossref","is-referenced-by-count":1,"title":["Anti-Mi2 Antibody Positive Dermatomyositis With Hyper-Elevated Creatine Kinase: A Case Report"],"prefix":"10.7759","author":[{"given":"Ryuichi","family":"Ohta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maika","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dermatomyositis","volume":"64","author":"Koler RA","year":"2001","unstructured":"Koler RA, Montemarano A. Dermatomyositis. Am Fam Physician. 2001, 64:1565-72.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1179547619855370","article-title":"Dermatomyositis: An acute flare and current treatments","volume":"12","author":"Okogbaa J","year":"2019","unstructured":"Okogbaa J, Batiste L. Dermatomyositis: An acute flare and current treatments. Clin Med Insights Case Rep. 2019, 12:1179547619855370. 10.1177\/1179547619855370","journal-title":"Clin Med Insights Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.7","article-title":"Treatment of dermatomyositis and polymyositis","volume":"41","author":"Choy EH","year":"2002","unstructured":"Choy EH, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford). 2002, 41:7-13. 10.1093\/rheumatology\/41.1.7","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1467257","article-title":"Current diagnosis and treatment of polymyositis and dermatomyositis","volume":"28","author":"Sasaki H","year":"2018","unstructured":"Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis. Mod Rheumatol. 2018, 28:913-21. 10.1080\/14397595.2018.1467257","journal-title":"Mod Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5175","article-title":"Dermatomyositis autoantibodies: How can we maximize utility?","volume":"9","author":"Hodgkinson LM","year":"2021","unstructured":"Hodgkinson LM, Wu TT, Fiorentino DF. Dermatomyositis autoantibodies: How can we maximize utility?. Ann Transl Med. 2021, 9:433. 10.21037\/atm-20-5175","journal-title":"Ann Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner IM","year":"2006","unstructured":"Bronner IM, van der Meulen MF, de Visser M, et al.. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis. 2006, 65:1456-61. 10.1136\/ard.2005.045690","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160753","article-title":"Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: A systematic review","volume":"11","author":"Leclair V","year":"2016","unstructured":"Leclair V, Regardt M, Wojcik S, Hudson M. Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: A systematic review. PLoS One. 2016, 11:e0160753. 10.1371\/journal.pone.0160753","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.48853","article-title":"Dermatomyositis presenting with rhabdomyolysis and acute renal failure; an uncommon manifestation","volume":"12","author":"Joshi D","year":"2009","unstructured":"Joshi D, Kumar N, Rai A. Dermatomyositis presenting with rhabdomyolysis and acute renal failure; an uncommon manifestation. Ann Indian Acad Neurol. 2009, 12:45-7. 10.4103\/0972-2327.48853","journal-title":"Ann Indian Acad Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12077","article-title":"Dermatomyositis-induced rhabdomyolysis with features of necrotizing myopathy and acute inflammatory demyelinating polyneuropathy in an Epstein-Barr virus infected patient","volume":"12","author":"Haikal A","year":"2020","unstructured":"Haikal A, Govil S, Anis A, Guma J. Dermatomyositis-induced rhabdomyolysis with features of necrotizing myopathy and acute inflammatory demyelinating polyneuropathy in an Epstein-Barr virus infected patient. Cureus. 2020, 12:e12077. 10.7759\/cureus.12077","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7956","article-title":"Dermatomyositis with rapidly progressive interstitial lung disease treated with rituximab: A report of 3 cases in Japan","volume":"56","author":"Tokunaga K","year":"2017","unstructured":"Tokunaga K, Hagino N. Dermatomyositis with rapidly progressive interstitial lung disease treated with rituximab: A report of 3 cases in Japan. Intern Med. 2017, 56:1399-403. 10.2169\/internalmedicine.56.7956","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0297-17","article-title":"Clinically amyopathic dermatomyositis with interstitial pneumonia that was successfully treated with plasma exchange","volume":"57","author":"Yagishita M","year":"2018","unstructured":"Yagishita M, Kondo Y, Terasaki T, et al.. Clinically amyopathic dermatomyositis with interstitial pneumonia that was successfully treated with plasma exchange. Intern Med. 2018, 57:1935-8. 10.2169\/internalmedicine.0297-17","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2020.3750","article-title":"Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis","author":"Liang L","year":"2020","unstructured":"Liang L, Zhang YM, Chen H, et al.. Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis. Eur J Dermatol. 2020, 10.1684\/ejd.2020.3750","journal-title":"Eur J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-019-0071-y","article-title":"Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis","volume":"59","author":"Dos Passos Carvalho MI","year":"2019","unstructured":"Dos Passos Carvalho MI, Shinjo SK. Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis. Adv Rheumatol. 2019, 59:27. 10.1186\/s42358-019-0071-y","journal-title":"Adv Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14739879.2020.1858349","article-title":"Realist evaluation of interprofessional education in primary care through transprofessional role play: what primary care professionals learn together","volume":"32","author":"Ohta R","year":"2021","unstructured":"Ohta R, Ryu Y, Yoshimura M. Realist evaluation of interprofessional education in primary care through transprofessional role play: what primary care professionals learn together. Educ Prim Care. 2021, 32:91-9. 10.1080\/14739879.2020.1858349","journal-title":"Educ Prim Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189479","article-title":"The seamless communication on a rural island in Japan: A qualitative study from the perspective of healthcare professionals","volume":"18","author":"Kuroda M","year":"2021","unstructured":"Kuroda M, Ohta R, Kuroda K, Yamashiro S, Kita K. The seamless communication on a rural island in Japan: A qualitative study from the perspective of healthcare professionals. Int J Environ Res Public Health. 2021, 18:10.3390\/ijerph18189479","journal-title":"Int J Environ Res Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063233","article-title":"Older people\u2019s help-seeking behaviors in rural contexts: A systematic review","volume":"19","author":"Ohta R","year":"2022","unstructured":"Ohta R, Ryu Y, Sano C. Older people\u2019s help-seeking behaviors in rural contexts: A systematic review. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph19063233","journal-title":"Int J Environ Res Public Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19116652","article-title":"Improvement in quality of life through self-management of mild symptoms during the COVID-19 pandemic: A prospective cohort study","volume":"19","author":"Ohta R","year":"2022","unstructured":"Ohta R, Ryu Y, Sano C. Improvement in quality of life through self-management of mild symptoms during the COVID-19 pandemic: A prospective cohort study. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph19116652","journal-title":"Int J Environ Res Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58060701","article-title":"Association between self-medication for mild symptoms and quality of life among older adults in rural Japan: A cross-sectional study","volume":"58","author":"Ohta R","year":"2022","unstructured":"Ohta R, Ryu Y, Sano C. Association between self-medication for mild symptoms and quality of life among older adults in rural Japan: A cross-sectional study. Medicina (Kaunas). 2022, 58:10.3390\/medicina58060701","journal-title":"Medicina (Kaunas)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041782","article-title":"Educational intervention to improve citizen\u2019s healthcare participation perception in rural Japanese communities: A pilot study","volume":"18","author":"Ohta R","year":"2021","unstructured":"Ohta R, Ryu Y, Kitayuguchi J, Sano C, K\u00f6nings KD. Educational intervention to improve citizen\u2019s healthcare participation perception in rural Japanese communities: A pilot study. Int J Environ Res Public Health. 2021, 18:10.3390\/ijerph18041782","journal-title":"Int J Environ Res Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/112197-anti-mi2-antibody-positive-dermatomyositis-with-hyper-elevated-creatine-kinase-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:47Z","timestamp":1707508067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/112197-anti-mi2-antibody-positive-dermatomyositis-with-hyper-elevated-creatine-kinase-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.28899","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,7]]}}}